Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer.

被引:0
|
作者
Ozkan-Dagliyan, Irem [1 ]
Goodwin, Craig M. [1 ]
Bryant, Kirsten L. [1 ]
George, Samuel D. [1 ]
Lucas, Kelly [1 ]
Gautam, Prson [2 ]
Wennerberg, Krister [2 ]
Cox, Adrienne D. [1 ]
Der, Channing J. [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Inst Mol Med Finland, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B31
引用
收藏
页码:68 / 68
页数:1
相关论文
共 50 条
  • [1] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
  • [2] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Xiufeng Pang
    Mingyao Liu
    Chinese Journal of Cancer, 2016, 35 (11) : 571 - 573
  • [3] A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Pang, Xiufeng
    Liu, Mingyao
    CHINESE JOURNAL OF CANCER, 2016, 35 : 92
  • [4] Targeting KRAS-mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
    Miyazaki, Satoru
    Kitazawa, Masato
    Nakamura, Satoshi
    Koyama, Makoto
    Yamamoto, Yuta
    Hondo, Nao
    Kataoka, Masahiro
    Tanaka, Hirokazu
    Takeoka, Michiko
    Komatsu, Daisuke
    Soejima, Yuji
    MOLECULAR ONCOLOGY, 2025, 19 (02) : 377 - 390
  • [5] MET inhibition radiosensitizes KRAS-mutant rectal cancer.
    D'Ambrosio, Antonio
    Verginelli, Federica
    Orzan, Francesca
    Albano, Raffaella
    Casanova, Elena
    Luraghi, Paolo
    De Bacco, Francesca
    Bertotti, Andrea
    Trusolino, Livio
    Senetta, Rebecca
    Sapino, Anna
    Del Mastro, Elena
    Gatti, Marco
    Comoglio, Paolo M.
    Boccaccio, Carla
    CANCER RESEARCH, 2021, 81 (13)
  • [6] Treating KRAS-Mutant Lung Cancer With Combination Agents
    Shumeyko, Emma P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (04) : 315 - 315
  • [7] Combination Immunotherapy with MEK Inhibitor for Treatment of Kras-Mutant Lung Cancer in Animal Model
    Lee, Jong Woo
    Zhang, Yu
    Choi, Justin
    Sharma, Roshan
    Park, Hee Sun
    Kaftan, Edward
    Papadimitrakopoulou, Vassiliki
    Herbst, Roy
    Koo, J. Peter
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1319 - S1319
  • [8] A novel combination strategy to treat KRAS-mutant lung cancer
    Peng, R. -W.
    Liang, S. -Q.
    Buhrer, E. D.
    Berezowska, S.
    Marti, T. M.
    Froment, L.
    Yang, H.
    Hall, S. R.
    Vassella, E.
    Yang, Z.
    Kocher, G. J.
    Amrein, M. J.
    Riether, C.
    Ochsenbein, A. F.
    Schmid, R. A.
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 19 - 19
  • [9] Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer
    Weisner, Joern
    Landel, Ina
    Reintjes, Christoph
    Uhlenbrock, Niklas
    Trajkovic-Arsic, Marija
    Dienstbier, Niklas
    Hardick, Julia
    Ladigan, Swetlana
    Lindemann, Marius
    Smith, Steven
    Quambusch, Lena
    Scheinpflug, Rebekka
    Depta, Laura
    Gontla, Rajesh
    Unger, Anke
    Mueller, Heiko
    Baumann, Matthias
    Schultz-Fademrecht, Carsten
    Guenther, Georgia
    Maghnouj, Abdelouahid
    Mueller, Matthias P.
    Pohl, Michael
    Teschendorf, Christian
    Wolters, Heiner
    Viebahn, Richard
    Tannapfel, Andrea
    Uhl, Waldemar
    Hengstler, Jan G.
    Hahn, Stephan A.
    Siveke, Jens T.
    Rauh, Daniel
    CANCER RESEARCH, 2019, 79 (09) : 2367 - 2378
  • [10] Combination therapies with CDK4/6 inhibitors to treat KRAS-mutant pancreatic cancer
    Goodwin, Craig M.
    Javaid, Sehrish
    Waters, Andrew M.
    Papke, Bjoern
    Yang, Runying
    Pierobon, Mariaelena
    Freed, Daniel M.
    Roberts, Patrick J.
    Cox, Adrienne D.
    Wood, Kris C.
    Petricoin, Emanuel F.
    Mcree, Autumn J.
    Der, Channing J.
    CANCER RESEARCH, 2019, 79 (13)